Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for galactorrhoea-hyperprolactinaemia has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
34 publications have been identified in PubMed for galactorrhoea-hyperprolactinaemia. Research spans Clinical Trial Publication (26%), Case Report / Case Series (24%), and Review / Meta-Analysis (21%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 9 | 26% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:53 PM UTC
Genetic and Rare Diseases Info Center
Patient case studies |
8 |
24% |
Research summaries | 7 | 21% |
Disease patterns and progression | 4 | 12% |
Testing and diagnosis research | 3 | 9% |
Other research | 1 | 3% |
Laboratory research | 1 | 3% |
New treatment approaches | 1 | 3% |
Sangngarm A (2026). [PMID: 41283705](https://pubmed.ncbi.nlm.nih.gov/41283705/). *International journal of psychiatry in clinical practice*. [Clinical Trial Publication]
Olasore HSA (2026). [PMID: 41888498](https://pubmed.ncbi.nlm.nih.gov/41888498/). *J Mol Neurosci*. [Review / Meta-Analysis]
McNeil JM (2026). [PMID: 41532055](https://pubmed.ncbi.nlm.nih.gov/41532055/). *Endocrine oncology (Bristol, England)*. [Clinical Trial Publication]
Bauer MJ (2026). [PMID: 42103527](https://pubmed.ncbi.nlm.nih.gov/42103527/). *Best Pract Res Clin Endocrinol Metab*. [Review / Meta-Analysis]
Bobet A (2026). [PMID: 41856891](https://pubmed.ncbi.nlm.nih.gov/41856891/). *Therapie*. [Other]
Kremenevski N (2026). [PMID: 42149391](https://pubmed.ncbi.nlm.nih.gov/42149391/). *Pituitary*. [Epidemiology / Natural History]
Humbert-Claude M (2026). [PMID: 42144793](https://pubmed.ncbi.nlm.nih.gov/42144793/). *BJPsych Open*. [Case Report / Case Series]
Xie F (2026). [PMID: 42083506](https://pubmed.ncbi.nlm.nih.gov/42083506/). *Clin Transl Med*. [Gene Therapy / Novel Therapeutics]
Brand BA (2026). [PMID: 41895316](https://pubmed.ncbi.nlm.nih.gov/41895316/). *Lancet Psychiatry*. [Review / Meta-Analysis]
Zerbinati L (2026). [PMID: 42149330](https://pubmed.ncbi.nlm.nih.gov/42149330/). *Pituitary*. [Epidemiology / Natural History]